se ha leído el artículo
array:24 [ "pii" => "S1578219016300750" "issn" => "15782190" "doi" => "10.1016/j.adengl.2016.05.005" "estado" => "S300" "fechaPublicacion" => "2016-07-01" "aid" => "1315" "copyright" => "Elsevier España, S.L.U. and AEDV" "copyrightAnyo" => "2015" "documento" => "article" "crossmark" => 1 "subdocumento" => "sco" "cita" => "Actas Dermosifiliogr. 2016;107:521-2" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 815 "formatos" => array:3 [ "EPUB" => 51 "HTML" => 594 "PDF" => 170 ] ] "Traduccion" => array:1 [ "es" => array:19 [ "pii" => "S0001731015005165" "issn" => "00017310" "doi" => "10.1016/j.ad.2015.07.019" "estado" => "S300" "fechaPublicacion" => "2016-07-01" "aid" => "1315" "copyright" => "AEDV" "documento" => "article" "crossmark" => 1 "subdocumento" => "sco" "cita" => "Actas Dermosifiliogr. 2016;107:521-2" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 309 "formatos" => array:3 [ "EPUB" => 4 "HTML" => 221 "PDF" => 84 ] ] "es" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Foro de Residentes</span>" "titulo" => "FR-¿Dónde posicionamos la combinación de antipalúdicos en el manejo del lupus eritematoso cutáneo refractario?" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "521" "paginaFinal" => "522" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Where Should We Position Antimalarial Drug Combinations in the Management of Refractory Cutaneous Lupus Erythematosus?" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "I. Pérez-López, A. Martínez-López, J. Tercedor-Sánchez, R. Ruiz-Villaverde" "autores" => array:4 [ 0 => array:2 [ "nombre" => "I." "apellidos" => "Pérez-López" ] 1 => array:2 [ "nombre" => "A." "apellidos" => "Martínez-López" ] 2 => array:2 [ "nombre" => "J." "apellidos" => "Tercedor-Sánchez" ] 3 => array:2 [ "nombre" => "R." "apellidos" => "Ruiz-Villaverde" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S1578219016300750" "doi" => "10.1016/j.adengl.2016.05.005" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219016300750?idApp=UINPBA000044" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731015005165?idApp=UINPBA000044" "url" => "/00017310/0000010700000006/v1_201606280028/S0001731015005165/v1_201606280028/es/main.assets" ] ] "itemSiguiente" => array:19 [ "pii" => "S1578219016300762" "issn" => "15782190" "doi" => "10.1016/j.adengl.2016.05.006" "estado" => "S300" "fechaPublicacion" => "2016-07-01" "aid" => "1324" "copyright" => "Elsevier España, S.L.U. and AEDV" "documento" => "article" "crossmark" => 1 "subdocumento" => "sco" "cita" => "Actas Dermosifiliogr. 2016;107:523" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 952 "formatos" => array:3 [ "EPUB" => 59 "HTML" => 766 "PDF" => 127 ] ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Images in Dermatology</span>" "titulo" => "Bednar Tumor Mimicking Congenital Melanocytic Nevus" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "523" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Tumor de Bednar simulando nevus melanocítico congénito" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:6 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 746 "Ancho" => 995 "Tamanyo" => 277445 ] ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "C. Bernárdez, A.M. Molina-Ruiz, L. Requena" "autores" => array:3 [ 0 => array:2 [ "nombre" => "C." "apellidos" => "Bernárdez" ] 1 => array:2 [ "nombre" => "A.M." "apellidos" => "Molina-Ruiz" ] 2 => array:2 [ "nombre" => "L." "apellidos" => "Requena" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0001731015005633" "doi" => "10.1016/j.ad.2015.04.027" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731015005633?idApp=UINPBA000044" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219016300762?idApp=UINPBA000044" "url" => "/15782190/0000010700000006/v2_201704050141/S1578219016300762/v2_201704050141/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S1578219016300981" "issn" => "15782190" "doi" => "10.1016/j.adengl.2015.04.025" "estado" => "S300" "fechaPublicacion" => "2016-07-01" "aid" => "131400" "copyright" => "Elsevier España, S.L.U. and AEDV" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "Actas Dermosifiliogr. 2016;107:519-20" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 1177 "formatos" => array:3 [ "EPUB" => 69 "HTML" => 938 "PDF" => 170 ] ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Case for Diagnosis</span>" "titulo" => "Follicular Papules and Erythematous Plaques on the Back" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "519" "paginaFinal" => "520" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Pápulas foliculares y placas eritematosas en espalda" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0010" "etiqueta" => "Figure 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 401 "Ancho" => 505 "Tamanyo" => 149965 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Hematoxylin and eosin, original magnification<span class="elsevierStyleHsp" style=""></span>x4.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "R. Ruiz-Villaverde, I. Pérez-López, J. Aneiros-Fernández" "autores" => array:3 [ 0 => array:2 [ "nombre" => "R." "apellidos" => "Ruiz-Villaverde" ] 1 => array:2 [ "nombre" => "I." "apellidos" => "Pérez-López" ] 2 => array:2 [ "nombre" => "J." "apellidos" => "Aneiros-Fernández" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0001731015005153" "doi" => "10.1016/j.ad.2015.04.025" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731015005153?idApp=UINPBA000044" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219016300981?idApp=UINPBA000044" "url" => "/15782190/0000010700000006/v2_201704050141/S1578219016300981/v2_201704050141/en/main.assets" ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Resident's Forum</span>" "titulo" => "Where Should We Position Antimalarial Drug Combinations in the Management of Refractory Cutaneous Lupus Erythematosus?" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "521" "paginaFinal" => "522" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "I. Pérez-López, A. Martínez-López, J. Tercedor-Sánchez, R. Ruiz-Villaverde" "autores" => array:4 [ 0 => array:4 [ "nombre" => "I." "apellidos" => "Pérez-López" "email" => array:1 [ 0 => "ipl_elmadrono@hotmail.com" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] 1 => array:2 [ "nombre" => "A." "apellidos" => "Martínez-López" ] 2 => array:2 [ "nombre" => "J." "apellidos" => "Tercedor-Sánchez" ] 3 => array:2 [ "nombre" => "R." "apellidos" => "Ruiz-Villaverde" ] ] "afiliaciones" => array:1 [ 0 => array:2 [ "entidad" => "Unidad de Gestión Clínica de Dermatología Médico Quirúrgica y Venereología, Hospital Universitario Virgen de las Nieves. Granada, Spain" "identificador" => "aff0005" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "FR-¿Dónde posicionamos la combinación de antipalúdicos en el manejo del lupus eritematoso cutáneo refractario?" ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">Topical therapy with high-potency corticosteroids or calcineurin inhibitors combined with synthetic antimalarial drugs achieves satisfactory disease control in the majority of patients with cutaneous lupus erythematosus. However, the management of refractory cases is a real challenge in daily clinical practice. Very few case series and clinical trials have been published, and it was only with the development and validation of the Cutaneous Lupus Erythematosus Disease Area and Severity Index (CLASI) in 2007 that it became possible to objectively assess the severity of the disease.<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">1</span></a></p><p id="par0010" class="elsevierStylePara elsevierViewall">The therapies most commonly used in refractory cases include particularly methotrexate, acitretin (with the highest level of evidence), mycophenolate mofetil, and dapsone. However, the combination of conventional antimalarial drugs (chloroquine [CQ] and hydroxychloroquine [HDQ]) with quinacrine (QN) is an option not always considered despite its good therapeutic results.</p><p id="par0015" class="elsevierStylePara elsevierViewall">QN, which is seldom used as it has to be requested for use as a foreign medication, is effective both in monotherapy and in combination with other antimalarials. In 2010, González-Sixto et al.<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">2</span></a> presented a retrospective series of 8 cases with excellent results after using QN in combined therapies to treat different forms of cutaneous lupus erythematosus. CQ and HDQ have similar therapeutic and ocular toxicity profiles, and their combined use is not therefore recommended. However, a therapeutic advantage of QN is its absence of retinal toxicity. In contrast, its side effects do include a risk of severe and potentially fatal aplastic anemia. Periodic (3-monthly) complete blood counts must therefore be performed to detect this anemia in its hypocellular phase, which resolves on withdrawal of the drug; this phase is occasionally preceded by nonspecific lichenoid eruptions.</p><p id="par0020" class="elsevierStylePara elsevierViewall">A number of case series in the literature have described the combined use of synthetic antimalarial drugs, but the regimen typically used is the one proposed by McCune and González-Rivera<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">3</span></a> in 2001: HDQ (at a dose not higher than 6.5<span class="elsevierStyleHsp" style=""></span>mg/kg/d) combined, when necessary, with QN (100<span class="elsevierStyleHsp" style=""></span>mg/d). If no adequate therapeutic response is observed after 6 to 8 weeks of combined therapy, HDQ is substituted by CQ (at a dose below 3.5<span class="elsevierStyleHsp" style=""></span>mg/kg/d) while continuing with QN. Recently, in a review by Rodríguez-Caruncho and Bielsa,<a class="elsevierStyleCrossRef" href="#bib0045"><span class="elsevierStyleSup">4</span></a> we were reminded of the realities of this association; those authors drew attention to a series of unresolved issues, including whether there is a time limit for the use of this combination, whether drug holidays can be used, why the cardioprotective effect of QN has still not been studied in sufficient detail, possible additional risks of the combination, and whether QN can potentiate other side effects of HDQ.<a class="elsevierStyleCrossRef" href="#bib0050"><span class="elsevierStyleSup">5</span></a></p><p id="par0025" class="elsevierStylePara elsevierViewall">In view of these considerations and on the basis of our own experience, we believe that, in the management of cutaneous lupus erythematosus refractory to conventional treatments, it is necessary to reposition the combination of antimalarial drugs as a therapeutic option to be used prior to employing other immunosuppressive agents or systemic retinoids.</p></span>" "pdfFichero" => "main.pdf" "tienePdf" => true "PalabrasClave" => array:1 [ "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec821301" "palabras" => array:4 [ 0 => "Cutaneous lupus" 1 => "Treatment" 2 => "Antimalarials" 3 => "Quinacrine" ] ] ] ] "NotaPie" => array:1 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as: Pérez-López I, Martínez-López A, Tercedor-Sánchez J, Ruiz-Villaverde R. FR-¿Dónde posicionamos la combinación de antipalúdicos en el manejo del lupus eritematoso cutáneo refractario?. Actas Dermosifiliogr. 2016;107:521–522.</p>" ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:5 [ 0 => array:3 [ "identificador" => "bib0030" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The CLASI (Cutaneous Lupus Erythematosus Disease Area and Severity Index): An outcome instrument for cutaneous lupus erythematosus" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J. Albrecht" 1 => "L. Taylor" 2 => "J.A. Berlin" 3 => "S. Dulay" 4 => "G. Ang" 5 => "S. Fakharzadeh" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.0022-202X.2005.23889.x" "Revista" => array:5 [ "tituloSerie" => "J Invest Dermatol" "fecha" => "2005" "volumen" => "125" "paginaInicial" => "889" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16297185" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0035" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Quinacrine in the treatment of cutaneous lupus erythematosus: Practical aspects and a case series [Article in Spanish]" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "B. González-Sixto" 1 => "I. García-Doval" 2 => "R. Oliveira" 3 => "C. Posada" 4 => "M.A. García-Cruz" 5 => "M. Cruces" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Actas Dermosifiliogr" "fecha" => "2010" "volumen" => "101" "paginaInicial" => "54" "paginaFinal" => "58" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20109393" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0040" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Should very low doses of hydroxychloroquine and quinacrine be employed in combination for long-term maintenance of remission in systemic lupus to reduce the risk of ocular toxicity?" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "W.J. McCune" 1 => "T. González-Rivera" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/BOR.0000000000000173" "Revista" => array:6 [ "tituloSerie" => "Curr Opin Rheumatol" "fecha" => "2015" "volumen" => "27" "paginaInicial" => "213" "paginaFinal" => "215" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25784384" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0045" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Antipalúdicos en dermatología: mecanismo de acción, indicaciones y efectos secundarios" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "C. Rodríguez-Caruncho" 1 => "I. Bielsa" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.adengl.2012.10.021" "Revista" => array:6 [ "tituloSerie" => "Actas Dermosifiliogr" "fecha" => "2014" "volumen" => "105" "paginaInicial" => "243" "paginaFinal" => "252" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24656224" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0050" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Coloración amarillenta inducida por quinacrina en una paciente con lupus eritematoso cutáneo" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "D. Vidal" 1 => "J. Altés" 2 => "J.A. Smandia" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.ad.2011.12.025" "Revista" => array:6 [ "tituloSerie" => "Actas Dermosifiliogr" "fecha" => "2013" "volumen" => "104" "paginaInicial" => "89" "paginaFinal" => "90" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22831783" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/15782190/0000010700000006/v2_201704050141/S1578219016300750/v2_201704050141/en/main.assets" "Apartado" => array:4 [ "identificador" => "34945" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Resident's Forum" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/15782190/0000010700000006/v2_201704050141/S1578219016300750/v2_201704050141/en/main.pdf?idApp=UINPBA000044&text.app=https://actasdermo.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219016300750?idApp=UINPBA000044" ]
año/Mes | Html | Total | |
---|---|---|---|
2024 Noviembre | 6 | 8 | 14 |
2024 Octubre | 68 | 41 | 109 |
2024 Septiembre | 62 | 20 | 82 |
2024 Agosto | 79 | 52 | 131 |
2024 Julio | 64 | 25 | 89 |
2024 Junio | 67 | 32 | 99 |
2024 Mayo | 61 | 25 | 86 |
2024 Abril | 69 | 27 | 96 |
2024 Marzo | 53 | 32 | 85 |
2024 Febrero | 41 | 27 | 68 |
2024 Enero | 48 | 28 | 76 |
2023 Diciembre | 49 | 12 | 61 |
2023 Noviembre | 66 | 26 | 92 |
2023 Octubre | 57 | 18 | 75 |
2023 Septiembre | 64 | 32 | 96 |
2023 Agosto | 36 | 11 | 47 |
2023 Julio | 45 | 27 | 72 |
2023 Junio | 42 | 18 | 60 |
2023 Mayo | 45 | 25 | 70 |
2023 Abril | 26 | 21 | 47 |
2023 Marzo | 32 | 17 | 49 |
2023 Febrero | 36 | 23 | 59 |
2023 Enero | 28 | 26 | 54 |
2022 Diciembre | 49 | 46 | 95 |
2022 Noviembre | 32 | 29 | 61 |
2022 Octubre | 24 | 17 | 41 |
2022 Septiembre | 32 | 35 | 67 |
2022 Agosto | 16 | 31 | 47 |
2022 Julio | 25 | 38 | 63 |
2022 Junio | 15 | 16 | 31 |
2022 Mayo | 24 | 37 | 61 |
2022 Abril | 49 | 28 | 77 |
2022 Marzo | 42 | 47 | 89 |
2022 Febrero | 24 | 28 | 52 |
2022 Enero | 38 | 31 | 69 |
2021 Diciembre | 33 | 38 | 71 |
2021 Noviembre | 33 | 49 | 82 |
2021 Octubre | 35 | 50 | 85 |
2021 Septiembre | 25 | 48 | 73 |
2021 Agosto | 20 | 33 | 53 |
2021 Julio | 21 | 35 | 56 |
2021 Junio | 21 | 24 | 45 |
2021 Mayo | 37 | 45 | 82 |
2021 Abril | 63 | 68 | 131 |
2021 Marzo | 56 | 19 | 75 |
2021 Febrero | 57 | 26 | 83 |
2021 Enero | 34 | 22 | 56 |
2020 Diciembre | 34 | 32 | 66 |
2020 Noviembre | 31 | 19 | 50 |
2020 Octubre | 26 | 12 | 38 |
2020 Septiembre | 31 | 12 | 43 |
2020 Agosto | 24 | 21 | 45 |
2020 Julio | 38 | 14 | 52 |
2020 Junio | 38 | 28 | 66 |
2020 Mayo | 25 | 9 | 34 |
2020 Abril | 28 | 16 | 44 |
2020 Marzo | 24 | 20 | 44 |
2020 Febrero | 7 | 1 | 8 |
2019 Diciembre | 10 | 0 | 10 |
2019 Noviembre | 4 | 0 | 4 |
2019 Septiembre | 8 | 0 | 8 |
2019 Agosto | 4 | 0 | 4 |
2019 Julio | 6 | 0 | 6 |
2019 Junio | 6 | 0 | 6 |
2019 Mayo | 4 | 0 | 4 |
2019 Abril | 3 | 1 | 4 |
2019 Marzo | 2 | 3 | 5 |
2019 Febrero | 2 | 0 | 2 |
2019 Enero | 1 | 0 | 1 |
2018 Diciembre | 6 | 0 | 6 |
2018 Noviembre | 1 | 0 | 1 |
2018 Octubre | 11 | 0 | 11 |
2018 Septiembre | 7 | 0 | 7 |
2018 Febrero | 30 | 3 | 33 |
2018 Enero | 36 | 6 | 42 |
2017 Diciembre | 59 | 11 | 70 |
2017 Noviembre | 22 | 7 | 29 |
2017 Octubre | 28 | 6 | 34 |
2017 Septiembre | 26 | 5 | 31 |
2017 Agosto | 31 | 6 | 37 |
2017 Julio | 24 | 4 | 28 |
2017 Junio | 34 | 9 | 43 |
2017 Mayo | 31 | 8 | 39 |
2017 Abril | 34 | 9 | 43 |
2017 Marzo | 18 | 11 | 29 |
2017 Febrero | 22 | 12 | 34 |
2017 Enero | 25 | 5 | 30 |
2016 Diciembre | 41 | 17 | 58 |
2016 Noviembre | 29 | 22 | 51 |
2016 Octubre | 21 | 19 | 40 |
2016 Julio | 3 | 6 | 9 |